FindTrial
Sign In

Study on the pathogenic gene of quadricuspid aortic valve

Study on the pathogenic gene of quadricuspid aortic valve

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052145
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-10-19
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quadricuspid Aortic Valve malformation

Interventions

group with quadricuspid aortic valve:No
group with tricuspid aortic valve:No
group with bicuspid aortic valve:No

Sponsors

The First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Both men and women are available, aged 18 to 70 years; 2. Aortic valve insufficiency requires surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Patients who fail to obtain informed consent; 2. Patients with severe valve calcification; 3. Other circumstances that the investigator considers unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
tricuspid aortic valve;quadricuspid aortic valve;bicuspid aortic valve;—

Countries

China

Contacts

Public ContactYi Wei

The First Affiliated Hospital of Air Force Military Medical University

yiwei@fmmu.edu.cn+86 13609126556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026